<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001754937</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001737287</issuerCik>
      <issuerName>Allogene Therapeutics, Inc.</issuerName>
      <secFileNumber>001-38693</secFileNumber>
      <issuerAddress>
        <com:street1>210 EAST GRAND AVENUE</com:street1>
        <com:city>SOUTH SAN FRANCISCO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94080</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(650) 457-2700</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MOORE ALISON</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Merrill Lynch</name>
        <address>
          <com:street1>225 Liberty St</com:street1>
          <com:street2>Floor 37</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10281</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>531854</noOfUnitsSold>
      <aggregateMarketValue>3052841.96</aggregateMarketValue>
      <noOfUnitsOutstanding>145841620</noOfUnitsOutstanding>
      <approxSaleDate>06/12/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>06/12/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>437080</amountOfSecuritiesAcquired>
      <paymentDate>06/12/2023</paymentDate>
      <natureOfPayment>Broker assisted cashless exercise</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>06/28/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>498</amountOfSecuritiesAcquired>
      <paymentDate>06/28/2019</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/13/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5512</amountOfSecuritiesAcquired>
      <paymentDate>03/13/2020</paymentDate>
      <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>08/13/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Exercise of employee stock options</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>32451</amountOfSecuritiesAcquired>
      <paymentDate>08/13/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/13/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>10799</amountOfSecuritiesAcquired>
      <paymentDate>03/13/2021</paymentDate>
      <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/13/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>23178</amountOfSecuritiesAcquired>
      <paymentDate>03/13/2022</paymentDate>
      <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/13/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>14829</amountOfSecuritiesAcquired>
      <paymentDate>03/13/2023</paymentDate>
      <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/15/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2000</amountOfSecuritiesAcquired>
      <paymentDate>03/15/2023</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/15/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1688</amountOfSecuritiesAcquired>
      <paymentDate>03/15/2022</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>09/15/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>558</amountOfSecuritiesAcquired>
      <paymentDate>09/15/2021</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/15/2021</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>368</amountOfSecuritiesAcquired>
      <paymentDate>03/15/2021</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>09/15/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>718</amountOfSecuritiesAcquired>
      <paymentDate>09/15/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/13/2020</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>704</amountOfSecuritiesAcquired>
      <paymentDate>03/13/2020</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>09/13/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>694</amountOfSecuritiesAcquired>
      <paymentDate>09/13/2019</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>03/15/2019</acquiredDate>
      <natureOfAcquisitionTransaction>Employee stock purchase plan</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Allogene Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>507</amountOfSecuritiesAcquired>
      <paymentDate>03/15/2019</paymentDate>
      <natureOfPayment>Cash</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Alison Moore</name>
        <address>
          <com:street1>210 EAST GRAND AVENUE</com:street1>
          <com:city>SOUTH SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94080</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>03/14/2023</saleDate>
      <amountOfSecuritiesSold>8351</amountOfSecuritiesSold>
      <grossProceeds>45989.75</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/12/2023</noticeDate>
      <signature>Alison Moore</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
